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In this study, a newly synthesized cytokine inhibitor FR167653 was investigated using a rat heart 
ischemia -reperfusion model to prove its myocardial protective effect and its role in the inhibition of cytokine 
production in ischemic myocardium. 
〔方法〕
Studies were performed with isolated, Langendorff-perfused Lewis rat hearts (n=80) which were either treated 
with FR167653 or untreated, as the control group, and subjected to ischemia-reperfusion. 
〔成績〕
Reperfusion followed by 30 minutes of 37
u
C ischemia induced marked myocardial cytokine expression and 
activated p38 MAPK. FR167653 administered before ischemia and during reperfusion significantly reduced 
ischemia -activated myocardial TNFαmRNA expression (190:t97 vs. 4805 :::t 3017, p=0.024) as well as TNFα 
production (0 ng/ml vs. 9.6土 2.5 ng/ml, pO.05) and also inhibited p38 MAPK activation. Its administration 
improved recovery of cardiac contractile function reperfusion : LVDP (1 30土 18 vs. 82士 21 mmHg (p=0.002)), 
max/min dP/dt (2812:t 3281ー2283 :::t216 vs. 1520士 4241ー 1325 :::t 237 mmHg/sec p=0.003). CPK leakage was 
significantly reduced in FR167653 treated hearts versus untreated hearts (54士 6 vs. 0.5土 0.1 ， P く 0.05) and 
reduction of coronary flow was improved (110:t 13% vs. 77士 11%) one hour after beginning of reperfusion (p < 
0.05). Moreover, FR administration attenuated the number of TUNEL positive cardiomyocytes (3:t 1 % vs. 9:1: 
2%). 
〔総括〕
These data demonstrated positive inotropic and antiapoptotic effects of a newly synthesized compound 




activation in ischemic・reperfused rat heart. This suggested that cytokine inhibition is significant as a method 




ードに注目し、新しい p38 MAPK選択的阻害剤である FR167653 の効果をラットランゲンドルフ潅流心により検討
した。その結果、サイトカイン TNFα誘導の遺伝子レベルでの抑制とアポトーシスの抑制効果がもたらされ、再濯流
後心機能が有意に改善することを明らかにしている。これらの結果は、本薬剤が新しい心筋保護作用を有する薬剤と
して有用である可能性を示唆するもので、今後心臓外科領域を中心に広く恩恵、をもたらす端緒となる研究成果である
といえる。よって本論文は学位の授与に値するものと考える。
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